| Trial ID: | L0198 |
| Source ID: | NCT00998972
|
| Associated Drug: |
N-Acetylcysteine
|
| Title: |
N-acetyl-cysteine (NAC) and Kidney Graft Function
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Brain Death|Chronic Renal Insufficiency
|
| Interventions: |
DRUG: N-acetylcysteine
|
| Outcome Measures: |
Primary: Incidence of delayed graft function, 1 year | Secondary: Evolution of creatininemia and azotemia during the first month after transplantation, 30 days|Intrahospital mortality, 30 days|Acute and delayed graft rejection, 30 days
|
| Sponsor/Collaborators: |
Sponsor: Institut d'Anesthesiologie des Alpes Maritimes
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
236
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2006-09
|
| Completion Date: |
2011-06
|
| Results First Posted: |
|
| Last Update Posted: |
2011-07-12
|
| Locations: |
CHU de Nice, NICE cedex 01, Alpes Maritimes, 06000, France
|
| URL: |
https://clinicaltrials.gov/show/NCT00998972
|
